FDA Inspection 1328488 — Shandong Anhong Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shandong Anhong Pharmaceutical Co., Ltd. on Jun 26, 2026 in Dezhou. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jun 26, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dezhou (China)